These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22749895)

  • 1. Myopathies associated with β-tropomyosin mutations.
    Tajsharghi H; Ohlsson M; Palm L; Oldfors A
    Neuromuscul Disord; 2012 Nov; 22(11):923-33. PubMed ID: 22749895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New morphologic and genetic findings in cap disease associated with beta-tropomyosin (TPM2) mutations.
    Ohlsson M; Quijano-Roy S; Darin N; Brochier G; Lacène E; Avila-Smirnow D; Fardeau M; Oldfors A; Tajsharghi H
    Neurology; 2008 Dec; 71(23):1896-901. PubMed ID: 19047562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital myopathy with nemaline rods and cap structures caused by a mutation in the beta-tropomyosin gene (TPM2).
    Tajsharghi H; Ohlsson M; Lindberg C; Oldfors A
    Arch Neurol; 2007 Sep; 64(9):1334-8. PubMed ID: 17846275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal actin binding of aberrant β-tropomyosins is a molecular cause of muscle weakness in TPM2-related nemaline and cap myopathy.
    Marttila M; Lemola E; Wallefeld W; Memo M; Donner K; Laing NG; Marston S; Grönholm M; Wallgren-Pettersson C
    Biochem J; 2012 Feb; 442(1):231-9. PubMed ID: 22084935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of beta-tropomyosin is a new cause of Escobar syndrome associated with nemaline myopathy.
    Monnier N; Lunardi J; Marty I; Mezin P; Labarre-Vila A; Dieterich K; Jouk PS
    Neuromuscul Disord; 2009 Feb; 19(2):118-23. PubMed ID: 19155175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cap disease caused by heterozygous deletion of the beta-tropomyosin gene TPM2.
    Lehtokari VL; Ceuterick-de Groote C; de Jonghe P; Marttila M; Laing NG; Pelin K; Wallgren-Pettersson C
    Neuromuscul Disord; 2007 Jun; 17(6):433-42. PubMed ID: 17434307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recurrent pathogenic variant in TPM2 reveals further phenotypic and genetic heterogeneity in multiple pterygium syndrome-related disorders.
    Vogt J; Al-Saedi A; Willis T; Male A; McKie A; Kiely N; Maher ER
    Clin Genet; 2020 Jun; 97(6):908-914. PubMed ID: 32092148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K7del is a common TPM2 gene mutation associated with nemaline myopathy and raised myofibre calcium sensitivity.
    Mokbel N; Ilkovski B; Kreissl M; Memo M; Jeffries CM; Marttila M; Lehtokari VL; Lemola E; Grönholm M; Yang N; Menard D; Marcorelles P; Echaniz-Laguna A; Reimann J; Vainzof M; Monnier N; Ravenscroft G; McNamara E; Nowak KJ; Laing NG; Wallgren-Pettersson C; Trewhella J; Marston S; Ottenheijm C; North KN; Clarke NF
    Brain; 2013 Feb; 136(Pt 2):494-507. PubMed ID: 23378224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygous intronic variants in TPM2 cause recessively inherited Escobar variant of multiple pterygium syndrome and congenital myopathy.
    Schirwani S; Sarkozy A; Phadke R; Childs AM; Mein R; Ismail A; Smith A; Muntoni F; Hobson E; Pysden K
    Neuromuscul Disord; 2021 Apr; 31(4):359-366. PubMed ID: 33558124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An alphaTropomyosin mutation alters dimer preference in nemaline myopathy.
    Corbett MA; Akkari PA; Domazetovska A; Cooper ST; North KN; Laing NG; Gunning PW; Hardeman EC
    Ann Neurol; 2005 Jan; 57(1):42-9. PubMed ID: 15562513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and phenotype of patients carrying TPM2 and TPM3 gene mutations in a cohort of 94 patients with congenital myopathy.
    Citirak G; Witting N; Duno M; Werlauff U; Petri H; Vissing J
    Neuromuscul Disord; 2014 Apr; 24(4):325-30. PubMed ID: 24507666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined cap disease and nemaline myopathy in the same patient caused by an autosomal dominant mutation in the TPM3 gene.
    Malfatti E; Schaeffer U; Chapon F; Yang Y; Eymard B; Xu R; Laporte J; Romero NB
    Neuromuscul Disord; 2013 Dec; 23(12):992-7. PubMed ID: 24095155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distal arthrogryposis and muscle weakness associated with a beta-tropomyosin mutation.
    Tajsharghi H; Kimber E; Holmgren D; Tulinius M; Oldfors A
    Neurology; 2007 Mar; 68(10):772-5. PubMed ID: 17339586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cap disease due to mutation of the beta-tropomyosin gene (TPM2).
    Clarke NF; Domazetovska A; Waddell L; Kornberg A; McLean C; North KN
    Neuromuscul Disord; 2009 May; 19(5):348-51. PubMed ID: 19345583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A locus on chromosome 15q for a dominantly inherited nemaline myopathy with core-like lesions.
    Gommans IM; Davis M; Saar K; Lammens M; Mastaglia F; Lamont P; van Duijnhoven G; ter Laak HJ; Reis A; Vogels OJ; Laing N; van Engelen BG; Kremer H
    Brain; 2003 Jul; 126(Pt 7):1545-51. PubMed ID: 12805120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-Body muscle MRI in a series of patients with congenital myopathy related to TPM2 gene mutations.
    Jarraya M; Quijano-Roy S; Monnier N; Béhin A; Avila-Smirnov D; Romero NB; Allamand V; Richard P; Barois A; May A; Estournet B; Mercuri E; Carlier PG; Carlier RY
    Neuromuscul Disord; 2012 Oct; 22 Suppl 2():S137-47. PubMed ID: 22980765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo missense mutation in a constitutively expressed exon of the slow alpha-tropomyosin gene TPM3 associated with an atypical, sporadic case of nemaline myopathy.
    Durling HJ; Reilich P; Müller-Höcker J; Mendel B; Pongratz D; Wallgren-Pettersson C; Gunning P; Lochmüller H; Laing NG
    Neuromuscul Disord; 2002 Dec; 12(10):947-51. PubMed ID: 12467750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel TPM2 gene splice-site mutation causes severe congenital myopathy with arthrogryposis and dysmorphic features.
    Mroczek M; Kabzińska D; Chrzanowska KH; Pronicki M; Kochański A
    J Appl Genet; 2017 May; 58(2):199-203. PubMed ID: 27726070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation update and genotype-phenotype correlations of novel and previously described mutations in TPM2 and TPM3 causing congenital myopathies.
    Marttila M; Lehtokari VL; Marston S; Nyman TA; Barnerias C; Beggs AH; Bertini E; Ceyhan-Birsoy O; Cintas P; Gerard M; Gilbert-Dussardier B; Hogue JS; Longman C; Eymard B; Frydman M; Kang PB; Klinge L; Kolski H; Lochmüller H; Magy L; Manel V; Mayer M; Mercuri E; North KN; Peudenier-Robert S; Pihko H; Probst FJ; Reisin R; Stewart W; Taratuto AL; de Visser M; Wilichowski E; Winer J; Nowak K; Laing NG; Winder TL; Monnier N; Clarke NF; Pelin K; Grönholm M; Wallgren-Pettersson C
    Hum Mutat; 2014 Jul; 35(7):779-90. PubMed ID: 24692096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital myopathies: diseases of the actin cytoskeleton.
    Clarkson E; Costa CF; Machesky LM
    J Pathol; 2004 Nov; 204(4):407-17. PubMed ID: 15495263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.